Skip to main content
Clinical Trials/NCT03210142
NCT03210142
Completed
Not Applicable

Minimally Invasive Hypoglossal Nerve Stimulation Study

Medtronic Cardiac Rhythm and Heart Failure3 sites in 1 country23 target enrollmentStarted: June 23, 2017Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Medtronic Cardiac Rhythm and Heart Failure
Enrollment
23
Locations
3
Primary Endpoint
Effect of transvenous hypoglossal nerve stimulation on tongue position

Overview

Brief Summary

The purpose of this study is to assess the effect of Transvenous Hypoglossal Nerve Stimulation (tHGNS) on tongue position in the upper airway. Activation of the HGN will cause contraction of the genioglossus muscle, which will move the tongue forward, opening the upper-airway and reducing apnea-hypopnea events in patients with Obstructive Sleep Apnea (OSA). A transvenous approach will be less risky and traumatic than current HGNS systems that require an open surgical approach to wrap a cuff electrode around the HGN.

Detailed Description

The primary objective is to determine the effect of tHGNS on tongue position in the upper airway in subjects undergoing an EP, cardiac catheterization or device procedure. (Measured as changes in the anteroposterior dimensions (2-dimensional) of the retropalatal and retrolingual airway spaces.) This will be an acute study lasting no more than 45 min during a standard new device implant, cardiac catheterization and/or EP procedure. The hypoglossal nerve will be stimulated from the lingual vein using various stimulation parameters. Tongue motion, upper airway opening or any side effects will be recorded. At the end of the test procedure all hardware - the catheters, lead and/or guide wire will be removed.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Device Feasibility
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subject is at least 18 years old
  • Subject is undergoing a standard new device implant, cardiac catheterization involving right heart catheterization and/or EP procedures
  • Subject is able and willing to give informed consent

Exclusion Criteria

  • Subject is unable or unwilling to participate with study procedures
  • Subject is pregnant (all women with childbearing potential must have a negative pregnancy test within 7 days prior to enrollment)
  • Subject is known to be allergic to radio opaque dye
  • Subject has a body mass index (BMI) \>40 kg/m2
  • Subject has had prior neck surgery that may interfere with vascular access to the lingual vein
  • Subject has had prior surgery of the oral cavity that may interfere with tongue or soft palate movement
  • Subject has a significant upper airway-related anatomic anomaly
  • Subject is enrolled in a concurrent study that may confound the results of this study.

Outcomes

Primary Outcomes

Effect of transvenous hypoglossal nerve stimulation on tongue position

Time Frame: During study procedure

Measured in changes in the anteroposterior dimensions (2-dimensional) of the retropalatal and retrolingual airway spaces from lateral fluoroscopic images.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Medtronic Cardiac Rhythm and Heart Failure
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (3)

Loading locations...

Similar Trials